Cargando…
Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous and aggressive hematologic malignancy that is associated with a high relapse rate and poor prognosis. Despite advances in immunotherapies in solid tumors and other hematologic malignancies, AML has been particularly difficult to treat with immunotherap...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571054/ https://www.ncbi.nlm.nih.gov/pubmed/37842238 http://dx.doi.org/10.20517/cdr.2023.39 |